MedPath

The development of electrophysiological readouts for migraine attack predictio

Recruiting
Conditions
Migraine
headache
10019231
Registration Number
NL-OMON55696
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
240
Inclusion Criteria

- Migraine with/ without aura or chronic migraine according to IHS /
ICHD-III-beta criteria
- Patients have to experience active migraine, which is defined for this study
as at least one migraine attack per month on average in the past 6 months.
- Age 18 years or older

Exclusion Criteria

General exclusion criteria for episodic migraine patients and healthy controls:
i) Severe depression and/or panic disorders and/or schizophrenia and/or
psychiatric disorders; ii) Epileptic disorders (epilepsy); iii) Severe visual
impairment; iv) Only for part 1: use of chronic medication (other than oral
contraceptives) in the four weeks preceding the investigation; v) Malignancy in
medical history; vi) only for part 2: use of (oral) contraceptives., Episodic
migraine patient specific: i) Only for part 1: use of prophylactic medication
for migraine in the four weeks preceding the investigation; ii) Inability to
differentiate between migraine and other variants of headache;
iii) Use of acute migraine or headache drugs on more than 6 days per month.,
Healthy control specific: i) Suffering from periodic pain attacks or a brain
disorder;
ii) Personal of family history in first-degree relatives of migraine or
trigeminal autonomic cephalgia (TAC); iii) More than one tension-type headache
in 3 months., Exclusion criteria for chronic migraine patients: i) Severe
depression and/or panic disorders and/or schizophrenia and/or psychiatric
disorders; ii) Epileptic disorders (epilepsy); iii) Severe visual impairment;
iv) Malignancy in medical history.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath